Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. ATAI Life Sciences N.V. shares valued at $290,502 were sold by Brand Florian on May 16 ’24. At $1.92 per share, Brand Florian sold 151,303 shares. The insider’s holdings dropped to 328,697 shares worth approximately $0.39 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Johnson Anne Nagengast sold 27,410 shares, netting a total of over 50,708 in proceeds. Following the sale of shares at $1.85 each, the insider now holds 73,590 shares.
Before that, Rao Srinivas had sold 61,640 shares from its account. In a trade valued at $114,034, the insider traded ATAI Life Sciences N.V. shares for $1.85 each. Upon closing the transaction, the insider’s holdings decreased to 61,640 shares, worth approximately $0.13 million.
As published in a research note from Maxim Group on April 03, 2024, ATAI Life Sciences N.V. [ATAI] has been rated up from a Hold to a Buy and the price target has been revised to $6. Analysts at Loop Capital started covering the stock with ‘”a Buy”‘ outlook in a report released in early November. As of November 30, 2021, Maxim Group has initiated its “Buy” rating for ATAI. Earlier on November 11, 2021, ROTH Capital initiated its rating. Their recommendation was “a Buy” for ATAI stock.
Analyzing ATAI Stock Performance
During the last five days, there has been a drop of approximately -4.84%. Over the course of the year, ATAI Life Sciences N.V. shares have dropped approximately -16.31%. Shares of the company reached a 52-week high of $2.8500 on 04/04/24 and a 52-week low of $1.1500 on 08/14/24. A 50-day SMA is recorded $1.3280, while a 200-day SMA reached $1.6366. Nevertheless, trading volume fell to 0.51 million shares from 0.37 million shares the previous day.
Support And Resistance Levels for ATAI Life Sciences N.V. (ATAI)
According to the 24-hour chart, there is a support level at 1.1667, which, if violated, would cause prices to drop to 1.1533. In the upper region, resistance lies at 1.1967. The next price resistance is at 1.2133. RSI (Relative Strength Index) is 39.31 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0476, which suggests the price will decrease in the coming days. Percent R is at 93.75%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Which companies own the most shares of ATAI Life Sciences N.V. (ATAI)?
On October 18, 2021, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $40.
